Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Palvella Therapeutics, Inc. (PVLA)

Biohaven Ltd. and Palvella Therapeutics, Inc. are both Biotechnology companies. Biohaven Ltd. and Palvella Therapeutics, Inc. are of similar size ($1.8B and $1.8B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against 146.7%. Across the 14 metrics below, Palvella Therapeutics, Inc. leads on 10 and Biohaven Ltd. on 4.

Valuation

Metric BHVN PVLA Biotechnology median
P/E n/m n/m 8.58
P/S 2.25 43.43 10.29
P/B 182.90 8.32 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m n/m 0.67
EV/Sales 2.24 37.43 9.89
Earnings yield (31.27%) (3.84%) (31.56%)
Free cash flow yield (23.79%) (1.78%) (23.42%)

Profitability

Metric BHVN PVLA Biotechnology median
Gross margin 0.00% 100.00% 65.77%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (799.46%) (46.63%) (54.09%)
Return on assets (127.41%) (37.70%) (47.78%)
Return on invested capital (9,245.36%) 0.00% 0.00%

Growth

Metric BHVN PVLA Biotechnology median
Revenue growth (TTM) 425.20% 146.67% 5.83%
EPS growth (last fiscal year) 26.08% 52.62% 29.36%
Revenue growth, 5-year CAGR — 8.03% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN PVLA Biotechnology median
Debt to equity 21.23 0.00 0.00
Current ratio 4.73 21.18 4.80
Net debt to EBITDA 0.11 1.50 0.97

Dividend

Metric BHVN PVLA Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric BHVN PVLA Biotechnology median
Market cap 1.77b 1.82b 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack